Company / PP&E (Net)
Guardant Health, Inc. PP&E (Net) History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$145.9M
FY2025
5-year range
$124.5M / $167.9M
FY2021-FY2025
Trend
+6.7%
vs FY2024
Sector context
#74 of 135
Health Care
What the data says
At $146M, Guardant Health, Inc.'s pp&e (net) ranks #74 of 135 in the Health Care sector. PP&E (Net) returned to growth in FY2025 after 2 years of decline, reaching $146M.
Based on SEC 10-K filings.
$146M in FY2025 with a 5-year CAGR of +18.4%.
Remained stable around $146M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -4.6%
- 5-Year CAGR
- +18.4%
- 10-Year CAGR
- -
Sector benchmark
#74 of 135 in Health CareTop 55% of 135This company $145.9M Sector average $1.4B
▼
-89.3% below sector average
Key checks
Key Insights
- 5-year CAGR of +18.4%, indicating consistent growth.
- In FY2025, pp&e (net) increased 6.7% year-over-year.
- Ranks #74 out of 135 companies in the Health Care sector.
- Peak pp&e (net) was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -1.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $145.9M | +6.7% |
| FY2024 | $136.8M | -5.7% |
| FY2023 | $145.1M | -13.6% |
| FY2022 | $167.9M | +34.9% |
| FY2021 | $124.5M | +98.2% |
| FY2020 | $62.8M | +43.8% |
| FY2019 | $43.7M | +40.9% |
| FY2018 | $31.0M | +93.3% |
| FY2017 | $16.0M | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026